Pharmacology of celecoxib in rat brain after kainate administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 846-852

  Ciceri, Paola ^a   Zhang, Yan ^a   Shaffer, Alex F ^a   Leahy, Kathleen M ^a   Woerner, Mark B ^a   Smith, Walter G ^a   Seibert, Karen ^a   Isakson, Peter C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; KAINIC ACID; MESSENGER RNA; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOHISTOLOGY; MALE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; SEIZURE; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BRAIN; BRAIN CHEMISTRY; CYCLOOXYGENASE INHIBITORS; DEXAMETHASONE; DNA PRIMERS; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; MALE; PROSTAGLANDINS; PYRAZOLES; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEIZURES; SPINAL CORD; SULFONAMIDES;

EID: 0036720458     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.302.3.846     Document Type: Article

References (41)

1. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
2. Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice
3. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus
4. The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity
5. Models of arthritis and the search for anti-arthritic drugs
6. Characterization of inducible cyclooxygenase in rat brain
7. Expression of cyclo-oxygenase 2 in rat brain following kainate treatment
8. Cyclooxygenase-2 mRNA induction in focal cerebral ischemia
9. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats
10. Inflammatory response: Pathway across the blood-brain barrier
11. Mechanisms of CNS response to systemic immune challenge: The febrile response
12. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison
13. Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders
14. The cycloxygenase-2 inhibitor SC-58236 is neuroprotective in an in vivo model of focal ischemia in the rat
15. Behavioral changes and expression of heat shock protein hsp-70 mRNA, brain-derived neurotrophic factor mRNA and cyclooxygenase-2 mRNA in rat brain following seizures induced by systemic administration of kainic acid
16. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice
17. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
18. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex
19. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2
20. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
21. The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus
22. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition
23. Cloning, expression and up-regulation of inducible rat prostaglandin E synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis
24. Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic
25. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
26. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia
27. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage
28. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia and interleukin 6 production in vivo
29. Interleukin-lbeta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity
30. Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2 and c-Fos in the rat brain after transient focal ischemia or kainic acid
31. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
32. Cysteinyl-leukotriene production during limbic seizures triggered by kainic acid
33. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
34. Pharmacological analysis of cyclooxygenase-1 in inflammation
35. Cyclooxygenases: Structural, cellular and molecular biology
36. Kainic acid seizures in the rat
37. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: Implications for Alzheimer's disease
38. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
39. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids
40. Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever
41. Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production